Published Aug 23, 2026
Dianthus Therapeutics (DNTH): Advancing a Complement-Centered Autoimmune Pipeline into Late-Stage Development
In-depth research on DNTH covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.
4,556 words20 min read
Read report